Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patients

Author: Mir Olivier  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.30, Iss.4, 2012-08, pp. : 1756-1760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract